The LathamTECH Podcast — Trade Secrets: The New Litigation Battleground
Podcast: Williams Mullen's Trending Now - An IP Podcast - When AI Meets Art: Litigation and Settlement Trends Affecting Artists
The Briefing: Vetter v. Resnik: When Copyright Termination Goes Global
IP Goes Pop! S7 Ep 1- We’re #1! Intellectual Property Firsts
Why Won't the USPTO Register My Last Name? — No Infringement Intended Podcast
The Briefing: Kat Von D, Miles Davis, and the Possible Death of the Intrinsic Test?
2026 Trends to Watch: Regulation, Infrastructure and IP in Motion
'Desk Drawer Roundup': NIL Contract Fights, Eligibility Battles, and the CSC Participation Agreement — Highway to NIL Podcast
The Briefing: Part Two: CCPA’s New Rules on Risk Assessments and Cybersecurity Audits
The Briefing: Part One: CCPA’s New Rules on Automated Decision making Technology (ADMT)
We get AI for work™: New Efforts to Ensure a National AI Policy
The Briefing: Why Lady Gaga Beat a Trademark Injunction Over “Mayhem”
Beyond the Deals: Student-Athlete Identity, Development, and NIL With 42U's Stephen Bienko — Highway to NIL Podcast
The Privacy Insider Podcast Episode 22: The Data Privacy of the Dead & Critiquing the Digital Divine with Carl Öhman of Uppsala University
Why Does Everyone Say 'The Big Game' Instead of 'Super Bowl'? — No Infringement Intended Podcast
The Briefing: Top Gun Cleared for Takeoff: The Ninth Circuit Affirms Paramount’s Copyright Win
The Briefing: The 2026 Forecast: Resolving Some of the Entertainment Industry’s Open Legal Issues
The Briefing: 2025 IP Resolutions Start With a Review of IP Assets (Featured)
Wolf Greenfield Attorneys Review 2025 and Look Ahead to 2026
The Briefing: New York Times v. Perplexity AI: Copyright, Hallucinations, and Trademark Risk
Our Patent Case Summaries provide a weekly summary of the precedential patent-related opinions issued by the Court of Appeals for the Federal Circuit and the opinions designated precedential or informative by the Patent Trial...more
Companies can sue for false advertising in various circumstances. If your company is facing revenue losses due to a competitor’s false or misleading statements or omissions in its advertisements, it will be worth ensuring...more
Generative AI is revolutionizing narrative design in games, turning every player into a co-author. But the same improvisation that makes AI NPCs so engaging also opens up new legal and platform risks. ...more
If we have learned anything from the last twelve years of patent eligibility jurisprudence, it is that the Federal Circuit continues to find new ways to disappoint. The Federal Circuit’s recent nonprecedential decision in...more
Result-oriented claims were found ineligible under 35 U.S.C ? 101 because the claims did not describe how the claimed results were achieved or how they embodied any specific technological improvement....more
The US Court of Appeals for the Federal Circuit affirmed a damages verdict amounting to tens of millions of dollars. The Court found that the patentee’s damages expert correctly apportioned value to the patented feature and...more
Welcome to Erise’s new Trademarks and our Favorite Sports Quarterly (we’re workshopping the name) and it’s the first Grand Prix week of 2026 for FORMULA 1TM fans! And, for those of us trademark and legal nerds, there is no...more
The US Court of Appeals for the Federal Circuit affirmed the district court’s grant of summary judgment of noninfringement of a means-plus-function claim element, emphasizing that a patentee must compare the accused product...more
Introduction- MedTech startups often validate their technology with academic partners. That makes sense as academic medical centers and research institutions offer what few partners can: sophisticated equipment, leading...more
Addressing subject matter eligibility in the life sciences context, the US Court of Appeals for the Federal Circuit reversed a district court’s summary judgment ruling that certain claims directed to genetically engineered...more
While the UDRP can be a fast and cost effective way to recover domain names registered in clear bad faith, it may not succeed in disputes involving legitimate competing rights, complex business relationships, or unresolved...more
Trade secret litigation often turns on fast-moving disputes over information, competition, and control. Each month, we highlight notable rulings, verdicts, and enforcement actions shaping trade secret risk and litigation...more
The European Patent Office (EPO) has announced that official fees for some services will increase on April 1, 2026, following the previous fee increase in April 2024. From April 1, 2026, the increase includes higher fees...more
REGENXBIO v. Trustees of UPenn, No. 2024-1408 (Fed. Cir. February 20, 2026) - Generally, someone may receive a patent for any new and useful process, machine, manufacture, or composition of matter. However, for over 75...more
A federal court in North Carolina recently put a mattress-topper design patent case to bed, dismissing the lawsuit at the pleadings stage after concluding that the accused product was “plainly dissimilar” from the patented...more
Wilson Sonsini is pleased to present The Scramble: 2025 Gaming Legal Year in Review. This annual publication offers a retrospective look at the game industry’s legal landscape of the past year, showcases Wilson Sonsini’s...more
On February 27, 2026, Genentech filed a complaint at the U.S. International Trade Commission (ITC) alleging that Biocon’s importation of its pertuzumab biosimilar, BMAB 1500/PERT-IJS (“BMAB 1500”), violates 19 U.S.C. § 1337...more
The ownership and licensing of design documents in professional services agreements play a significant role in protecting the interests of the design professional and the project owner during and after project completion. The...more
On Feb. 20, 2026, the United States Court of Appeals for the Federal Circuit (“Federal Circuit”) issued a thoughtful analysis of biotechnology subject-matter eligibility in REGENXBIO, Inc. v. Sarepta Therapeutics, Inc., No....more
Google Threat Intelligence Group (GTIG) recently reported that cybercriminals—in particular, state-sponsored threat actors from North Korea, Iran, China, and Russia—are misusing Gemini, Google’s large language model (LLM), to...more
Businesses routinely group customer data, pricing models, internal processes, and strategic plans under the “trade secret” umbrella without much analysis. That shorthand works until litigation, at which point the difference...more
2025 data reflects a rebalancing of risk and capital allocation in early-stage licensing & collaboration deals, with proportionately more value being allocated earlier in development and modest compression in back-end...more
Artificial intelligence may be global, but patent eligibility remains stubbornly local. A recent decision out of the Supreme Court of the United Kingdom seems to have nudged UK practice for computer-implemented inventions...more
Case details: Abbott Diabetes Care v. MicroTech, Lotus NL, Mediq UPC_CFI_830/2025, February 6, 2026....more
In early 2026, the U.S. Supreme Court (the “Court”) agreed to hear a case at the heart of pharmaceutical intellectual property that could have significant implications for the manufacturers of both patented and generic drugs....more